β3-adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy

Hormone and Metabolic Research

Volumn 30, Issue 10, 1998, Pages 629-632

  Baba, T ^a,b   Nakajima, S ^b   Yajima, Y ^b  

^a KITASATO UNIVERSITY   (Japan)

^b Dohtai Clinic Kajiwara   (Japan)

Author keywords

Hypertension; NIDDM; Obesity; 3 Adrenergic Receptor

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; DNA; ARGININE; BETA ADRENERGIC RECEPTOR; TRYPTOPHAN;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; GENE MUTATION; HUMAN; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE; CODON; GENETICS; MIDDLE AGED; MUTATION;

ADULT; AGED; ARGININE; CODON; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTATION; RECEPTORS, ADRENERGIC, BETA; TRYPTOPHAN;

EID: 0031593636     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978947     Document Type: Article

References (29)

1. Drury PL. Diabetes and hypertension. Diabetologia 1983; 26: 1-9
2. Ebstein M, Sowers JR. Diabetes and hypertension. Hypertension 1992; 19: 403-18
3. Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987: 30: 123-31
4. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christiansen NJ, et al. Central role of sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 610-7
5. O'Hare JA, Ferris JB, Brady D, Towmey B, O'Sullivan DJ. Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 1985; 7 (Suppl. II): 43-8
6. O'Hare JA, Ferris JB, Twomey B, Conggrijp H, O'Sullivan DJ. Changes in blood pressure, body fluids, circulating angiotensin II and aldosterone with improved diabetic control. Clin Sci 1982; 63 (Suppl. 8): 415-8
7. Beretta-Piccoli C, Weidmann P. Exaggerated pressor responsiveness to norepinephrine in diabetic patients. Am J Med 1981; 71: 829-36
8. Drury PL, Smith GM, Ferris JB. Increased vasopressor responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia 1984; 27: 174-9
9. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M. et al. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-7
10. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809-17
11. Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416-22
12. 3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995; 333: 348-51
13. 3-adrenergic receptor gene. N Engl J Med 1995; 333: 343-7
14. 3-adrenergic receptor with NIDDM and body weight gain. Diabetologia 1996; 39: 349-52
15. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 1995; 333: 352-4
16. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Comm 1995; 215: 555-60
17. Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC-V). Arch Intern Med 1993; 153: 154-83
18. Sakane N, Yoshida T, Yoshioka K, Nakamura Y, Umekawa T, et al. Beta 3-adrenergic receptor gene polymorphism: a newly identified risk factor for proliferative retinopathy in NIDDM patients. Diabetes 1997; 46: 1633-6
19. Krolewski AS, Canessa M, Warram JH, Laffel LMB, Christlieb AR, et al. Predisposition of hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140-5
20. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent patients. Br Med J 1987; 195: 575-7
21. Jensen JS, Mathiesen ER, Nøgaard K, Hommel E, Borch-Johnsen K, et al. Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia 1990; 33: 619-24
22. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy: An 8-year prospective study. Kidlnt 1992; 41: 822-8
23. Mogensen CE. Management of the diabetic patient with hypertension: early screening and treatment programs. In: Laragh JH, Brenner BM (eds): Hypertension: pathology, diagnosis, and management. New York: Raven Press Ltd., 1995: 1717-39
24. Houston MC. Treatment of hypertension in diabetes mellitus. Am Heart J 1989; 118: 819-29
25. United Kingdom Prospective Diabetes Study. III. Prevalence of hyertension and hypotensive therapy in patients with newly diagnosed diabetes. Hypertension 1985; 7 (Suppl. 2): II5-II13
26. Groop LC, Kankuri M, Schalin-Jantti C, et al. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 10-4
27. Kadowaki T, Kadowaki H, Yazaki Y. Polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus. N Engl J Med 1993; 328: 1568-9
28. Almind K, Vestergaard H, Hansen T, Echwald S, Pederson O. Amino acid polymorphism of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993; 342: 828-32
29. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS. Insulin receptor substrate-I variants in non-insulin-dependent diabetes. J Clin Invest 1994; 94: 1141-6